Navigation Links
NexBio Completes Clinical Advisory Board for the Advanced Development of DAS181 (Fludase(R)*), a First-In-Class Medicine for Influenza
Date:4/15/2009

SAN DIEGO, April 15 /PRNewswire/ -- NexBio, Inc. announced today that it has completed the formation of a new Clinical Advisory Board (CAB) to complement its existing group of Senior Advisers. NexBio recently completed a First-In-Man clinical trial of DAS181 (Fludase(R)), an investigational drug candidate for influenza. The new CAB will guide NexBio throughout the clinical development of this novel medicine, helping the company to conduct advanced product development to address the threat of a potential influenza pandemic. The CAB is chaired by Andrew Pavia, M.D., who is joined by Robert Belshe, M.D., Kathryn Edwards, M.D., Allison McGeer, M.D., FRCPC, and Richard Whitley, M.D.

"These individuals are among the most highly regarded thought leaders in the field of clinical development of drugs for respiratory viral infections," said Ron Moss, M.D., NexBio's Executive Vice President, Clinical Development & Medical Affairs. "We expect that their depth of knowledge and experience will contribute enormously to the goal of developing Fludase for the prevention and treatment of Influenza-Like Illness caused by influenza, parainfluenza, and potential pandemic strains such as H5N1. With the development of drug resistance to currently licensed antivirals, our distinguished CAB recognizes the importance of determining the clinical utility of DAS181 against emerging strains of influenza."

Dr. Pavia is the George and Esther Gross Presidential Professor and Chief of the Division of Pediatric Infectious Diseases at the University of Utah Health Sciences Center. He is very active as an infectious disease investigator and in policy. Dr. Pavia serves on several advisory committees for federal and state government on vaccine policy, biodefense, and pandemic influenza preparedness. He leads several committees of the Infectious Diseases Society of America and has been a member of the Institute of Medicine C
'/>"/>

SOURCE NexBio, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. NexBio to Present at 2009 Biotech Showcase
2. Zenobia Therapeutics Successfully Completes Initial Phase of Its Service Agreement With Syntonix Pharmaceuticals
3. NeoStem Completes $11 Million Private Placement Financing to Support Expansion Activities in China, Further Development of NeoStems VSEL Technology and Advancement of Medical Tourism Initiatives
4. Gen-Probe Completes Acquisition of Tepnel Life Sciences
5. Transgenomic Completes Licensing Option With Dana-Farber Cancer Institute on Cold-PCR for Enrichment of DNA Mutations
6. SAFC Biosciences(TM) Completes Conversion of Lenexa Media Milling Facility to Animal Component Free
7. Atritech Completes $30 Million Financing
8. Roche Completes Tender Offer for Genentech
9. Oncolytics Biotech(R) Inc. Completes Enrolment in Combination REOLYSIN(R)/Gemcitabine Trial
10. China Biologic Products Completes Acquisition of 35% Interest in Xian Huitian Blood Products Co., Ltd.
11. Sangart, Inc. Completes Series F Funding Round
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... and TORONTO , March 5, 2015 ... clinical-stage company developing new therapeutics and molecular diagnostics that ... William G. Rice , Ph.D., Chairman, President and ... Annual ROTH Conference on Tuesday, March 10 th ... Laguna Niguel, CA. Dr. Rice ...
(Date:3/5/2015)... Chardon, Ohio (PRWEB) March 05, 2015 ... and Gold Development Partner located in Northeast Ohio, today ... chosen e2b teknologies to support its upgrade to the ... As the largest independent group practice of its kind ... base and large volume of transactions, so efficiency and ...
(Date:3/4/2015)... -- In an article published and posted online today, ... review the clinical aspects of diseases caused by 5 ... article, "Clinical Management of Potential Bioterrorism-Related Conditions," was published ... New England Journal of Medicine . ... Tom Inglesby—review the clinical management of conditions resulting from ...
(Date:3/4/2015)... , Mar. 04, 2015 Research and ... the addition of Jain PharmaBiotech,s new report ... their offering. This report follows ... characteristic that can be objectively measured and evaluated ... processes as well as pharmacological responses to a ...
Breaking Biology Technology:Aptose Biosciences to Present at the 27th Annual ROTH Conference 2Aptose Biosciences to Present at the 27th Annual ROTH Conference 3Physician Group Practice Chooses e2b teknologies to Support Its Upgrade to Sage 100 ERP 2014 2Latest Clinical Information On Bioterrorism Threats 2Global Biomarkers Report 2014-2024 - Technologies, Markets and Companies 2Global Biomarkers Report 2014-2024 - Technologies, Markets and Companies 3
... to biological systems? Until now, says Prof. Ron Naaman ... both biologists and physicists have considered quantum systems and ... research he conducted together with scientists in Germany, which ... a biological molecule DNA can discern between ...
... Tiens Biotech Group (USA), Inc. (the "Company" or "Tiens", NYSE ... to the research, development, manufacturing, and marketing of nutrition supplement ... announced financial results for the year ended December 31, 2010. ... $62.0 million for 2009.   Net income for ...
... SHANGHAI, March 31, 2011 /PRNewswire-Asia-FirstCall/ -- China-Biotics, Inc. (Nasdaq: ... leading developer, manufacturer and distributor of probiotics products in ... product sales order from its newly signed U.S. customer. ... its first sales order, and formally entered into its ...
Cached Biology Technology:Biological molecules select their spin 2Tiens Biotech Group (USA) Reports 2010 Results 2Tiens Biotech Group (USA) Reports 2010 Results 3Tiens Biotech Group (USA) Reports 2010 Results 4Tiens Biotech Group (USA) Reports 2010 Results 5Tiens Biotech Group (USA) Reports 2010 Results 6Tiens Biotech Group (USA) Reports 2010 Results 7China-Biotics Receives First U.S. Sales Order 2China-Biotics Receives First U.S. Sales Order 3
(Date:2/18/2015)... , Feb. 18, 2015  Cepheid (NASDAQ: CPHD ... the following conferences, and invited investors to participate via webcast. ... Boston, MA Tuesday, March 3, 2015 at 11.20 ... Orlando, FL Wednesday, March 4, 2015 ... To access the live webcasts for these events, please visit ...
(Date:2/12/2015)... 12, 2015   MedNet Solutions , a ... study management systems, has recently bolstered its ... iMedNet as the eClinical ... and healthcare consultants.  Building on the Program,s existing ... and numerous co-marketing opportunities), MedNet,s new and improved ...
(Date:2/11/2015)... February 11, 2015 ... "Access Control Market by Product (Cards and Readers, Biometrics, ... Defense, Government, Industrial, Healthcare, Education) and By Geography - Global ... MarketsandMarkets, the Access Control Market is expected ... at a CAGR of 10.6% between 2014 ...
Breaking Biology News(10 mins):Cepheid to Webcast Upcoming Financial Presentations 2MedNet Solutions Announces Key Enhancements To Its iMedNet Partner Program 2Access Control Market Worth $10.4 Billion by 2020 2Access Control Market Worth $10.4 Billion by 2020 3Access Control Market Worth $10.4 Billion by 2020 4
... existence of life in outer space may have a surprisingly ... Understanding how life evolved on Earth is important in obtaining ... find life and what it might be like, said George ... is finishing work on a three-year research grant from NASA's ...
... attracts developing sensory nerves up the spinal cord toward ... in the opposite direction, down the cord and away ... Chicago in the September 2005 issue of Nature Neuroscience ... restore function to people with paralyzing spinal cord injuries. ...
... computer simulation whose results have enhanced scientific understanding ... by the National Institutes of Health, appears in ... the National Academy of Sciences. , Previous research ... histone proteins and DNA--exhibits salt-dependent conformations. Specifically, chains ...
Cached Biology News:Evolution of life on Earth may hold key to finding life in outer space 2Evolution of life on Earth may hold key to finding life in outer space 3Gradient guides nerve growth down spinal cord 2Gradient guides nerve growth down spinal cord 3
Human PDGF R beta MAb (Clone # PR7212)...
Recombinant Mouse IL-23, CF...
Rabbit Serum New Zealand or California Origin...
Collected from 8-12 week old New Zealand or Californian rabbits. Aseptically collected and processed to minimize hemolytic activity. Pricing: $60/unit for 1 - 10 units...
Biology Products: